Fintel reports that on January 7, 2025, Guggenheim downgraded their outlook for Palo Alto Networks (NasdaqGS:PANW) from ...

LEXINGTON, Mass. and AMSTERDAM, Jan. 08, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, ...

Maze Therapeutics has filed for an initial public offering with the Securities and Exchange Commission. The San Francisco-based human genetics biotech company didn't say Tuesday how many shares it ...

LEXINGTON, Mass. and AMSTERDAM, Jan. 08, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, ...

Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of 2024 in its ...

Danaher (NYSE:DHR – Get Free Report) had its price objective cut by analysts at Citigroup from $305.00 to $285.00 in a note ...

Range Financial Group LLC acquired a new stake in GSK plc (NYSE:GSK – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange ...

The article showcases diverse global destinations with unique experiences and recent developments. From Jane Austen's ...

Financial analysts at Guggenheim rate Quanta Services as Neutral due to its high valuation compared to historical averages, while MasTec and ...

Guggenheim analysts rate MasTec (MTZ) and Primoris Services (PRIM) as Buy, expecting gains from electrification infrastructure projects in the US.

Discover Weiss/Manfredi's architectural journey from award-winning designs to innovative landscape urbanism in New York and beyond.

American States Water Cut to Underweight From Equal-Weight by Wells Fargo American Water Works Raised to Equal-Weight From Underweight by Wells Fargo Excelerate Energy Cut to Underweight From Neutral ...